In drug development news, FDA granted accelerated approval for Boehringer’s Hernexeos (zongertinib) as a first-line HER2-mutant non-small cell lung cancer treatment in just 44 days, utilizing the ...
TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Q4 2025 Earnings Call Transcript March 5, 2026 TriSalus Life Sciences, Inc. beats earnings expectations. Reported EPS is $-0.12, expectations were $-0.13.
TD Cowen 46th Annual Health Care Conference March 4, 2026 9:50 AM ESTCompany ParticipantsAlexander Schuth - Co-Founder, ...
[Audio Gap] Sylvie, and I will be your conference operator today. [Operator Instructions] As a reminder, note that this conference call is being broadcast live on the Internet and recorded. I would ...
Alberta has retroactively published its final draw of February, inviting workers holding job offers in rural in-province communities to apply for provincial nomination. This most recent draw (February ...